Physician
Internal Medicine
Dr. Alexander Pokov, MD
|
|
Give Review
Alexander Pokov is an expert in the field of Internal Medicine. He researched medicine at National Medical University Kiev. Alexander Pokov is a published doctor and has 16 publications published. The lastest was: 'Disbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: The cangrelor efficacy challenge.' He is registered with Medicare and accepts Medicare payments.
Publications
- Disbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: The cangrelor efficacy challenge.
- Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel.
- Criticality of pH for accurate fluorometric measurements of dipyridamole levels in biological fluids.
- Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia.
- A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humans.
- Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients...
- Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Tr...
- Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study.
- Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study).
- Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans.
- Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
- Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
- Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial.
- Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.
- Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: f...
Schools
National Medical University Oobohomolets
MD Genl Hospital
Lehigh Vly Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
National Medical University Kiev
Drug Facts
| NPI NUMBER | 1114931532 | |
| NPPES Provider LastName | POKOV | |
| NPPES Provider FirstName | ALEXANDER | |
| NPPES Provider ZIPCode | 21215 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 19644.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 197.0 | |
| Percent Opioid Claims | 1.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114931532 |
| Last Name Of The Provider | POKOV |
| First Name Of The Provider | ALEXANDER |
| View All |
Similar Doctors
|
|
Dr. Carla W. Rosenthal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara V. Akin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Walsh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ambika Sharma, MD |
|
|
Dr. Maura J. McGuire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tara A. Ryan, MD |
|
|
Dr. Stanley C. Chen Cardenas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan Chu, MD |
|
|
Dr. Wassim W. Labaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eunice Yang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabra Lewsey, MD |
|
|
Dr. Shazia F. Mehmood, MD |
|
|
Dr. Keiko I. Greenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryana Shenderov, MD
This Doctor is OpenDoctor Recommended.
|